Application number | Title of the application | Filing Date | Status |
---|
07/549172 | THIONATED ANALOGUES OF THYROTHROPIN RELEASING HORMONE | Jul 5, 1990 | Abandoned |
Array
(
[id] => 2934599
[patent_doc_number] => 05189148
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-02-23
[patent_title] => 'Stabilized FGF composition and production thereof'
[patent_app_type] => 1
[patent_app_number] => 7/547454
[patent_app_country] => US
[patent_app_date] => 1990-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8910
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/189/05189148.pdf
[firstpage_image] =>[orig_patent_app_number] => 547454
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/547454 | Stabilized FGF composition and production thereof | Jul 2, 1990 | Issued |
Array
(
[id] => 2885399
[patent_doc_number] => 05109117
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-04-28
[patent_title] => 'Method of somatotropin naturation using urea and a soluble organic alcohol'
[patent_app_type] => 1
[patent_app_number] => 7/543906
[patent_app_country] => US
[patent_app_date] => 1990-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2925
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/109/05109117.pdf
[firstpage_image] =>[orig_patent_app_number] => 543906
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/543906 | Method of somatotropin naturation using urea and a soluble organic alcohol | Jun 25, 1990 | Issued |
Array
(
[id] => 2919269
[patent_doc_number] => 05234904
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-08-10
[patent_title] => 'Antihypertensives containing polysaccharide peptidoglycan complexes extracted from the cell wall of lactic acid bacteria'
[patent_app_type] => 1
[patent_app_number] => 7/542734
[patent_app_country] => US
[patent_app_date] => 1990-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4695
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/234/05234904.pdf
[firstpage_image] =>[orig_patent_app_number] => 542734
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/542734 | Antihypertensives containing polysaccharide peptidoglycan complexes extracted from the cell wall of lactic acid bacteria | Jun 21, 1990 | Issued |
Array
(
[id] => 2756820
[patent_doc_number] => 05043428
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-08-27
[patent_title] => 'Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production'
[patent_app_type] => 1
[patent_app_number] => 7/538695
[patent_app_country] => US
[patent_app_date] => 1990-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3042
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/043/05043428.pdf
[firstpage_image] =>[orig_patent_app_number] => 538695
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/538695 | Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production | Jun 17, 1990 | Issued |
07/530649 | WOUND HEALING | May 29, 1990 | Abandoned |
Array
(
[id] => 2883553
[patent_doc_number] => RE034271
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-06-01
[patent_title] => 'Production of alpha-alpha cross-linked hemoglobins in high yield'
[patent_app_type] => 2
[patent_app_number] => 7/528331
[patent_app_country] => US
[patent_app_date] => 1990-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6991
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/034/RE034271.pdf
[firstpage_image] =>[orig_patent_app_number] => 528331
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/528331 | Production of alpha-alpha cross-linked hemoglobins in high yield | May 23, 1990 | Issued |
Array
(
[id] => 2673801
[patent_doc_number] => 05073630
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-12-17
[patent_title] => 'Polymeric anhydride of magnesium and proteic ammonium phospholinoleate with antiviral, antineoplastic and immunostimulant properties'
[patent_app_type] => 1
[patent_app_number] => 7/527581
[patent_app_country] => US
[patent_app_date] => 1990-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 3660
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/073/05073630.pdf
[firstpage_image] =>[orig_patent_app_number] => 527581
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/527581 | Polymeric anhydride of magnesium and proteic ammonium phospholinoleate with antiviral, antineoplastic and immunostimulant properties | May 22, 1990 | Issued |
Array
(
[id] => 2805181
[patent_doc_number] => 05147854
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-09-15
[patent_title] => 'TGF-B compositions and method'
[patent_app_type] => 1
[patent_app_number] => 7/527215
[patent_app_country] => US
[patent_app_date] => 1990-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 4562
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/147/05147854.pdf
[firstpage_image] =>[orig_patent_app_number] => 527215
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/527215 | TGF-B compositions and method | May 21, 1990 | Issued |
07/514053 | FIBRONECTIN PREPARATIONS | Apr 23, 1990 | Abandoned |
Array
(
[id] => 2836639
[patent_doc_number] => 05171567
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-12-15
[patent_title] => 'Method for the treatment of ATLL and the inhalant for the same'
[patent_app_type] => 1
[patent_app_number] => 7/494216
[patent_app_country] => US
[patent_app_date] => 1990-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3960
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/171/05171567.pdf
[firstpage_image] =>[orig_patent_app_number] => 494216
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/494216 | Method for the treatment of ATLL and the inhalant for the same | Mar 14, 1990 | Issued |
Array
(
[id] => 2717354
[patent_doc_number] => 05008372
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-04-16
[patent_title] => 'Deblocking amino terminal N-acetyl serine and N-acetyl threonine residues in peptides and proteins to allow sequencing'
[patent_app_type] => 1
[patent_app_number] => 7/478917
[patent_app_country] => US
[patent_app_date] => 1990-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2309
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/008/05008372.pdf
[firstpage_image] =>[orig_patent_app_number] => 478917
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/478917 | Deblocking amino terminal N-acetyl serine and N-acetyl threonine residues in peptides and proteins to allow sequencing | Feb 11, 1990 | Issued |
Array
(
[id] => 2774940
[patent_doc_number] => 05075424
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-12-24
[patent_title] => 'Process for producing .kappa.-casein glycomacropeptides'
[patent_app_type] => 1
[patent_app_number] => 7/476196
[patent_app_country] => US
[patent_app_date] => 1990-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2537
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/075/05075424.pdf
[firstpage_image] =>[orig_patent_app_number] => 476196
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/476196 | Process for producing .kappa.-casein glycomacropeptides | Feb 6, 1990 | Issued |
07/472730 | NOVEL TREATMENT METHOD | Jan 30, 1990 | Abandoned |
Array
(
[id] => 2778377
[patent_doc_number] => 05151499
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-09-29
[patent_title] => 'Production method for protein-containing composition'
[patent_app_type] => 1
[patent_app_number] => 7/464077
[patent_app_country] => US
[patent_app_date] => 1990-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5329
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/151/05151499.pdf
[firstpage_image] =>[orig_patent_app_number] => 464077
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/464077 | Production method for protein-containing composition | Jan 11, 1990 | Issued |
Array
(
[id] => 2857917
[patent_doc_number] => 05149692
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-09-22
[patent_title] => 'Bisalkoxyphosphinyl compounds as renin inhibitors'
[patent_app_type] => 1
[patent_app_number] => 7/454795
[patent_app_country] => US
[patent_app_date] => 1989-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10461
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/149/05149692.pdf
[firstpage_image] =>[orig_patent_app_number] => 454795
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/454795 | Bisalkoxyphosphinyl compounds as renin inhibitors | Dec 20, 1989 | Issued |
Array
(
[id] => 2783674
[patent_doc_number] => 05087694
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-02-11
[patent_title] => 'Fluorinated gelatin and process for its preparation'
[patent_app_type] => 1
[patent_app_number] => 7/451169
[patent_app_country] => US
[patent_app_date] => 1989-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3555
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/087/05087694.pdf
[firstpage_image] =>[orig_patent_app_number] => 451169
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/451169 | Fluorinated gelatin and process for its preparation | Dec 14, 1989 | Issued |
07/438365 | GHILANTEN: ANTIMETASTATIC PRINCIPLE FROM THE SOUTH AMERICAN LEECH, HAEMENTERIA GHILIANII | Dec 13, 1989 | Abandoned |
Array
(
[id] => 2714946
[patent_doc_number] => 05008242
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-04-16
[patent_title] => 'Treatment of inflammation using 1-antichymotrypsin'
[patent_app_type] => 1
[patent_app_number] => 7/445005
[patent_app_country] => US
[patent_app_date] => 1989-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2428
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/008/05008242.pdf
[firstpage_image] =>[orig_patent_app_number] => 445005
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/445005 | Treatment of inflammation using 1-antichymotrypsin | Dec 3, 1989 | Issued |
Array
(
[id] => 2737739
[patent_doc_number] => 05077391
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-12-31
[patent_title] => 'Purification of immunoglobulin M'
[patent_app_type] => 1
[patent_app_number] => 7/444547
[patent_app_country] => US
[patent_app_date] => 1989-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 1
[patent_no_of_words] => 2209
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/077/05077391.pdf
[firstpage_image] =>[orig_patent_app_number] => 444547
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/444547 | Purification of immunoglobulin M | Nov 30, 1989 | Issued |